GlucoTrack, Inc. , a medical device company, designs, develops, and commercializes non-invasive glucose monitoring devices for use by people suffering from diabetes and pre-diabetics in Israel and internationally.
Glucotrack stock last closed at $0.49, down 5.22% from the previous day, and has decreased 97.87% in one year. It has underperformed other stocks in the Medical Instruments & Supplies industry by 0.95 percentage points. Glucotrack stock is currently +7.46% from its 52-week low of $0.46, and -99.51% from its 52-week high of $99.00.
There are currently 288,601 GCTK shares outstanding. The market value of GCTK is $141.41k. In the last 24 hours, 6.04M GCTK shares were traded.
You need an online brokerage account in order to access the NASDAQ market and buy GCTK stock.
Based on our research, eToro is the best place to buy stocks. Here's why:
Get $10 towards your purchase of shares by opening an account with eToro now.
Open eToro AccountNow that you've picked your brokerage, the next step is to fill out some personal details so you can invest in GCTK today.
Now that you've opened your account on apps for stocks, you can securely and quickly fund your account:
Watch the walkthrough below if you need help transferring money into your new brokerage account.
Once you have figured out the best place to buy Glucotrack stock, it's crucial to analyze their stock prior to buying, so you can understand the risk and opportunity.
WallStreetZen was built to help average investors perform better fundamental analysis quickly.
You can see all of the due diligence checks on GCTK's stock page.
Analysts use a variety of different financial metrics, analyses, models, and charts to gauge GCTK's fair value.
You can access additional valuation research on GCTK's stock here.
Last year, GCTK revenue was $0.00. During the last five year, GCTK's revenue has increased by -100% per year. This was slower than the Medical Instruments & Supplies industry average of 10.49%.
Dive into GCTK's earnings and revenue performance here.
Over the past 12 months, executives and large shareholders at GCTK have bought more shares than they have sold.
Drew Sycoff, Director of GCTK, was the latest GCTK insider to buy. They bought $229,999.14 worth of GCTK shares on Apr 22, 2024.
Get more info about who owns GCTK shares here.
No, Glucotrack doesn't provide an income stream by paying out dividends.
One of the primary reasons eToro is our highest-rated brokerage is because of its social trading community.
Click below to find out what other traders have to say.
There are two main options:
Click the Open button and eToro will execute your order.
If you need more help investing in stocks on eToro, click the helpful video below:
Now that you own some shares in GCTK, you'll want to keep up with your new investment.
Make a watchlist to monitor your GCTK stock.
To summarize, here are the 6 steps for buying Glucotrack stock:
If you need a brokerage, eToro is our favorite option.
Get Started with eToro TodayIf you would like to get updates on your new investment in Glucotrack, click the button below.